CA Stock MarketDetailed Quotes

EPRX Eupraxia Pharmaceuticals Inc

Watchlist
  • 3.700
  • +0.220+6.32%
15min DelayMarket Closed Aug 9 16:00 ET
131.80MMarket Cap-2908P/E (TTM)

Eupraxia Pharmaceuticals Inc Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
(Q3)Sep 30, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
-80.53%-7.71M
-34.01%-6.12M
-43.68%-20.68M
-34.91%-6.11M
-44.78%-5.73M
-52.89%-4.27M
-46.79%-4.57M
-25.36%-14.4M
-62.42%-4.53M
-126.05%-3.96M
Net income from continuing operations
36.21%-6.06M
-55.63%-6.16M
-52.53%-28.97M
-28.63%-10.86M
-68.41%-4.65M
-98.88%-9.51M
-31.37%-3.96M
-3.61%-18.99M
-184.32%-8.44M
25.45%-2.76M
Operating gains losses
190.79%58.15K
844.56%144.91K
72.44%-59.76K
-269.68%-57.59K
98.74%-2.7K
122.32%20K
-136.25%-19.46K
-122.96%-216.83K
8.15%33.94K
-31.62%-214.87K
Depreciation and amortization
10.25%42.03K
-0.10%37.42K
5.16%155.53K
-0.03%46.86K
1.75%33.09K
3.12%38.12K
18.79%37.46K
69.08%147.89K
44.22%46.88K
46.05%32.52K
Unrealized gains and losses of investment securities
-111.79%-430.5K
-345.17%-770.04K
-20.79%836.6K
-204.26%-1.18M
---1.95M
--3.65M
--314.08K
--1.06M
--1.13M
----
Remuneration paid in stock
246.13%1.47M
-32.86%213.13K
-1.50%1.41M
-56.34%320.1K
330.28%348.61K
115.21%426.12K
-24.71%317.42K
-56.62%1.43M
70.85%733.19K
-69.32%81.02K
Other non cashItems
-59.15%51.7K
1.68%160.94K
-11.20%586K
-65.06%107.28K
797.56%193.88K
-28.94%126.56K
-21.87%158.29K
-75.32%659.95K
49.77%307.07K
-117.04%-27.79K
Change In working capital
-392.93%-2.84M
117.63%250.12K
253.35%5.35M
232.25%5.51M
129.46%293.34K
-41.58%971.06K
-75.31%-1.42M
1,013.35%1.51M
419.20%1.66M
-159.86%-995.65K
-Change in receivables
-62.70%13.67K
919.02%17.2K
-145.00%-103.71K
-161.48%-124.11K
-42.27%-17.94K
-22.29%36.65K
128.34%1.69K
53.95%230.48K
178.68%201.88K
79.53%-12.61K
-Change in prepaid assets
-270.84%-884.76K
143.49%125.2K
-206.40%-122.44K
-123.48%-10.46K
-36.70%75.18K
-17.27%-238.58K
31,838.22%51.42K
-178.18%-39.96K
-74.85%44.54K
-33.68%118.78K
-Change in payables and accrued expense
-268.24%-1.97M
107.32%107.71K
321.28%5.58M
299.82%5.64M
121.43%236.1K
-35.50%1.17M
-83.18%-1.47M
461.12%1.32M
420.86%1.41M
-171.28%-1.1M
Cash from discontinued investing activities
Operating cash flow
-80.53%-7.71M
-34.01%-6.12M
-43.68%-20.68M
-34.91%-6.11M
-44.78%-5.73M
-52.89%-4.27M
-46.79%-4.57M
-25.36%-14.4M
-62.42%-4.53M
-126.05%-3.96M
Investing cash flow
Cash flow from continuing investing activities
379.37%17.66K
15.85%-6.79K
-100.75%-73.38K
-100.30%-49.69K
-102.49%-9.3K
99.91%-6.32K
-48.63%-8.07K
186.78%9.83M
334.36%16.57M
314.95%373.94K
Net PPE purchase and sale
379.37%17.66K
15.85%-6.79K
68.82%-73.38K
31.33%-49.69K
68.38%-9.3K
95.07%-6.32K
-48.63%-8.07K
30.50%-235.31K
-405.82%-72.36K
90.81%-29.4K
Net investment purchase and sale
----
----
--0
--0
----
----
----
242.66%10.07M
335.80%16.64M
--403.34K
Cash from discontinued investing activities
Investing cash flow
379.37%17.66K
15.85%-6.79K
-100.75%-73.38K
-100.30%-49.69K
-102.49%-9.3K
99.91%-6.32K
-48.63%-8.07K
186.78%9.83M
334.36%16.57M
314.95%373.94K
Financing cash flow
Cash flow from continuing financing activities
-198.01%-4.5M
11,797.52%23.15M
94.55%21.01M
-83.98%188.71K
2,659.43%16.04M
-55.37%4.59M
638.09%194.61K
-72.41%10.8M
1,271.48%1.18M
22.15%-626.69K
Net issuance payments of debt
-127,324.75%-4.5M
-3.36%-36.82K
-1.52%-144.44K
10.39%-37.52K
-124.71%-67.77K
89.64%-3.53K
1.51%-35.62K
-101.50%-142.27K
46.42%-41.87K
-163.34%-30.16K
Net common stock issuance
--0
--22.85M
49.36%15.89M
-94.75%47.92K
2,755.10%15.84M
--0
--0
-64.15%10.64M
4,173.22%912.94K
30.03%-596.54K
Proceeds from stock option exercised by employees
--0
46.46%337.2K
1,618.51%5.27M
-41.88%178.31K
--268.94K
--4.59M
--230.23K
--306.77K
--306.77K
--0
Cash from discontinued financing activities
Financing cash flow
-198.01%-4.5M
11,797.52%23.15M
94.55%21.01M
-83.98%188.71K
2,659.43%16.04M
-55.37%4.59M
638.09%194.61K
-72.41%10.8M
1,271.48%1.18M
22.15%-626.69K
Net cash flow
Beginning cash position
157.81%35.91M
5.90%19.34M
45.75%18.26M
183.07%24.43M
6.85%14.42M
3.01%13.93M
9.14%18.26M
10,542.18%12.53M
-67.30%8.63M
-53.61%13.5M
Current changes in cash
-4,001.35%-12.19M
488.67%17.03M
-95.88%256.97K
-145.20%-5.97M
344.60%10.3M
-19.04%312.55K
-38.94%-4.38M
-61.79%6.24M
232.69%13.22M
-54.25%-4.21M
Effect of exchange rate changes
-317.86%-397.62K
-1,122.24%-460.76K
261.89%821.4K
197.55%819K
-180.07%-225.19K
64.46%182.51K
175.10%45.07K
-692.55%-507.4K
-1,689.49%-839.6K
765.41%281.24K
End cash Position
61.66%23.32M
157.81%35.91M
5.90%19.34M
5.90%19.34M
183.07%24.43M
6.85%14.42M
3.01%13.93M
11.46%18.26M
11.46%18.26M
-67.30%8.63M
Free cash from
-80.51%-7.72M
-33.92%-6.13M
-41.87%-20.76M
-33.87%-6.16M
-43.95%-5.74M
-46.39%-4.28M
-46.80%-4.58M
-23.76%-14.63M
-64.18%-4.6M
-92.53%-3.99M
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
--
--
--
--
--
Unqualified Opinion with Explanatory Notes
--
--
(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022(Q3)Sep 30, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities -80.53%-7.71M-34.01%-6.12M-43.68%-20.68M-34.91%-6.11M-44.78%-5.73M-52.89%-4.27M-46.79%-4.57M-25.36%-14.4M-62.42%-4.53M-126.05%-3.96M
Net income from continuing operations 36.21%-6.06M-55.63%-6.16M-52.53%-28.97M-28.63%-10.86M-68.41%-4.65M-98.88%-9.51M-31.37%-3.96M-3.61%-18.99M-184.32%-8.44M25.45%-2.76M
Operating gains losses 190.79%58.15K844.56%144.91K72.44%-59.76K-269.68%-57.59K98.74%-2.7K122.32%20K-136.25%-19.46K-122.96%-216.83K8.15%33.94K-31.62%-214.87K
Depreciation and amortization 10.25%42.03K-0.10%37.42K5.16%155.53K-0.03%46.86K1.75%33.09K3.12%38.12K18.79%37.46K69.08%147.89K44.22%46.88K46.05%32.52K
Unrealized gains and losses of investment securities -111.79%-430.5K-345.17%-770.04K-20.79%836.6K-204.26%-1.18M---1.95M--3.65M--314.08K--1.06M--1.13M----
Remuneration paid in stock 246.13%1.47M-32.86%213.13K-1.50%1.41M-56.34%320.1K330.28%348.61K115.21%426.12K-24.71%317.42K-56.62%1.43M70.85%733.19K-69.32%81.02K
Other non cashItems -59.15%51.7K1.68%160.94K-11.20%586K-65.06%107.28K797.56%193.88K-28.94%126.56K-21.87%158.29K-75.32%659.95K49.77%307.07K-117.04%-27.79K
Change In working capital -392.93%-2.84M117.63%250.12K253.35%5.35M232.25%5.51M129.46%293.34K-41.58%971.06K-75.31%-1.42M1,013.35%1.51M419.20%1.66M-159.86%-995.65K
-Change in receivables -62.70%13.67K919.02%17.2K-145.00%-103.71K-161.48%-124.11K-42.27%-17.94K-22.29%36.65K128.34%1.69K53.95%230.48K178.68%201.88K79.53%-12.61K
-Change in prepaid assets -270.84%-884.76K143.49%125.2K-206.40%-122.44K-123.48%-10.46K-36.70%75.18K-17.27%-238.58K31,838.22%51.42K-178.18%-39.96K-74.85%44.54K-33.68%118.78K
-Change in payables and accrued expense -268.24%-1.97M107.32%107.71K321.28%5.58M299.82%5.64M121.43%236.1K-35.50%1.17M-83.18%-1.47M461.12%1.32M420.86%1.41M-171.28%-1.1M
Cash from discontinued investing activities
Operating cash flow -80.53%-7.71M-34.01%-6.12M-43.68%-20.68M-34.91%-6.11M-44.78%-5.73M-52.89%-4.27M-46.79%-4.57M-25.36%-14.4M-62.42%-4.53M-126.05%-3.96M
Investing cash flow
Cash flow from continuing investing activities 379.37%17.66K15.85%-6.79K-100.75%-73.38K-100.30%-49.69K-102.49%-9.3K99.91%-6.32K-48.63%-8.07K186.78%9.83M334.36%16.57M314.95%373.94K
Net PPE purchase and sale 379.37%17.66K15.85%-6.79K68.82%-73.38K31.33%-49.69K68.38%-9.3K95.07%-6.32K-48.63%-8.07K30.50%-235.31K-405.82%-72.36K90.81%-29.4K
Net investment purchase and sale ----------0--0------------242.66%10.07M335.80%16.64M--403.34K
Cash from discontinued investing activities
Investing cash flow 379.37%17.66K15.85%-6.79K-100.75%-73.38K-100.30%-49.69K-102.49%-9.3K99.91%-6.32K-48.63%-8.07K186.78%9.83M334.36%16.57M314.95%373.94K
Financing cash flow
Cash flow from continuing financing activities -198.01%-4.5M11,797.52%23.15M94.55%21.01M-83.98%188.71K2,659.43%16.04M-55.37%4.59M638.09%194.61K-72.41%10.8M1,271.48%1.18M22.15%-626.69K
Net issuance payments of debt -127,324.75%-4.5M-3.36%-36.82K-1.52%-144.44K10.39%-37.52K-124.71%-67.77K89.64%-3.53K1.51%-35.62K-101.50%-142.27K46.42%-41.87K-163.34%-30.16K
Net common stock issuance --0--22.85M49.36%15.89M-94.75%47.92K2,755.10%15.84M--0--0-64.15%10.64M4,173.22%912.94K30.03%-596.54K
Proceeds from stock option exercised by employees --046.46%337.2K1,618.51%5.27M-41.88%178.31K--268.94K--4.59M--230.23K--306.77K--306.77K--0
Cash from discontinued financing activities
Financing cash flow -198.01%-4.5M11,797.52%23.15M94.55%21.01M-83.98%188.71K2,659.43%16.04M-55.37%4.59M638.09%194.61K-72.41%10.8M1,271.48%1.18M22.15%-626.69K
Net cash flow
Beginning cash position 157.81%35.91M5.90%19.34M45.75%18.26M183.07%24.43M6.85%14.42M3.01%13.93M9.14%18.26M10,542.18%12.53M-67.30%8.63M-53.61%13.5M
Current changes in cash -4,001.35%-12.19M488.67%17.03M-95.88%256.97K-145.20%-5.97M344.60%10.3M-19.04%312.55K-38.94%-4.38M-61.79%6.24M232.69%13.22M-54.25%-4.21M
Effect of exchange rate changes -317.86%-397.62K-1,122.24%-460.76K261.89%821.4K197.55%819K-180.07%-225.19K64.46%182.51K175.10%45.07K-692.55%-507.4K-1,689.49%-839.6K765.41%281.24K
End cash Position 61.66%23.32M157.81%35.91M5.90%19.34M5.90%19.34M183.07%24.43M6.85%14.42M3.01%13.93M11.46%18.26M11.46%18.26M-67.30%8.63M
Free cash from -80.51%-7.72M-33.92%-6.13M-41.87%-20.76M-33.87%-6.16M-43.95%-5.74M-46.39%-4.28M-46.80%-4.58M-23.76%-14.63M-64.18%-4.6M-92.53%-3.99M
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions --------------Unqualified Opinion with Explanatory Notes----

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Heat List
CA
Overall
Symbol
Latest Price
% Chg